Despite prevailing financial turbulence and concerns over falling bond prices, financial experts encourage continued investment for the future. They emphasize the importance of regular contributions to pensions and ISAs, advocating for a long-term commitment to investing even during volatile periods.
This strategy involves a core-satellite approach, where the majority of a portfolio is invested in stable funds, while smaller "satellite" holdings are allocated to sectors with high growth potential. These satellite funds, while volatile, are believed to offer the possibility of significant returns and diversification.
Space Exploration
The global space sector is gaining momentum, with annual revenues projected to triple by 2035. SpaceX's recent market debut has underscored the increasing commercialization of space, extending beyond traditional rocket and satellite systems to encompass broader economic infrastructure. Investment opportunities include direct shares in companies like SpaceX, investment trusts such as Seraphim Space Investment Trust, which holds both listed and unlisted space businesses, and exchange-traded funds (ETFs) like Van Eck's Space Innovators (JEDG) and iShares' Space Technologies (STRR). The recent launch of the Seraphim New Space UCITS ETF (SERA) offers a consolidated approach to investing in a mix of public and private space companies.
Robotics and Automation
While artificial intelligence has dominated recent investment discussions, the robotics sector is also experiencing significant growth. Innovations are evident across various applications, from industrial automation and warehouse management to advanced humanoid robots. Experts highlight the expanding role of robots in enhancing business productivity and their potential in areas like assisted healthcare and autonomous driving. Recommended funds include iShares Automation & Robotics and L&G Global Robotics and Automation, which have shown considerable returns and offer geographic diversification. The Pictet Robotics fund has also demonstrated strong performance, though it includes significant holdings in AI companies like Nvidia and ASML.
Biotechnology
The biotechnology sector, encompassing genomics, immunotherapy, and gene editing, is at the forefront of medical advancements, particularly in the fight against diseases like cancer. Companies in this field can generate substantial financial rewards, with potential for significant investor returns. However, the sector is characterized by high risks, including the possibility of clinical trial failures, regulatory delays, and the need for substantial capital before profitability. For investors, diversified exposure through funds is recommended. International Biotechnology (IBT), RTW Biotech Opportunities (RTW), and Polar Capital Biotechnology are cited as established funds with strong track records. The RTW fund, in particular, is noted for its focus on breakthrough innovations in public and private markets.
Emerging Markets and UK Smaller Companies
Beyond these thematic areas, investors can consider pre-emerging markets and UK smaller companies. Vietnam is identified as a country poised for emerging market status, which is expected to attract significant investment capital. Funds focusing on Vietnam include Vietnam Enterprise Investments, VinaCapital Vietnam Opportunity, and Vietnam Holding.
UK smaller companies, which have been overlooked in recent years, are also presenting opportunities. Some managers are identifying undervalued companies, achieving notable returns. Funds such as Onward Opportunities, Aberforth Smaller Companies, and Odyssean are mentioned as options for investors looking to tap into this segment of the market.